Spyre Therapeutics

Spyre Therapeutics, formerly Aeglea BioTherapeutics, is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection.

Year Established: 2013 Stock Ticker: SYRE Exchange: NASDAQ

Locations

  • Spyre Therapeutics

     Waltham MA

    Spyre Therapeutics, formerly Aeglea BioTherapeutics, is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection.

  • Spyre Therapeutics

     Austin TX

    Spyre Therapeutics, formerly Aeglea BioTherapeutics, is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection.